-
Current and Future Immunotherapy for Breast Cancer
Published on December 25, 2024, in the Journal of Hematology & Oncology, this review explores the evolving role of immunotherapy in breast cancer treatment, highlighting key advancements in immune checkpoint…
-
ERBB2+ Metastatic Breast Cancer and CNS Disease: Survival Insights
A new study examines survival outcomes and CNS-related mortality among patients with ERBB2+ metastatic breast cancer (MBC) and central nervous system (CNS) disease. Among the 274 patients analyzed, 55.2% of…
-
Advancing Early-Stage HCC Detection: Multicenter Evaluation of Abbreviated MRI vs. Ultrasound
New research evaluates the effectiveness of abbreviated MRI (AMRI) compared to ultrasound in detecting early-stage hepatocellular carcinoma (HCC). Findings suggest that AMRI significantly outperforms ultrasound in sensitivity and specificity, particularly…
-
The World’s Top 2% Scientists List is Out!
Recently, Professor John P.A. Ioannidis and his team from Stanford University, in collaboration with Elsevier, have released the World’s Top 2% Scientists list. This list primarily focuses on the “Career-long Impact” which measures the scientific influence throughout an academic career, as well as the “Single-year Impact” which highlights annual scientific achievements. Based on in-depth analysis…
-
World Breast Cancer Awareness Month | Renowned Physicians’ Protection, Building a Healthy Future Together —— Focusing on Breast Cancer Prevention and Treatment (1)
Professor Qingyuan Zhang（Harbin Medical University Cancer Hospital）： Currently, the incidence of breast cancer worldwide has surpassed that of lung cancer, becoming the number one cancer in humans and seriously threatening…
-
World Breast Cancer Awareness Month | Renowned Physicians’ Protection, Building a Healthy Future Together —— Focusing on Breast Cancer Prevention and Treatment (2)
Professor Guangyu Liu（Fudan University Shanghai Cancer Center）： Breast cancer is a major threat to women’s health globally and is increasingly drawing widespread attention from all sectors of society. As we…
-
Professor Yehui Shi: The Epigenetic Regulation of HR+ Metastatic Breast Cancer—A Review of the Development Path of HDACi Entinostat
Histone deacetylases (HDACs) are histone-modifying enzymes that regulate epigenetic changes. They control the acetylation process of histone post-translational modifications by removing the N-acetyl group from acetylated lysine residues in histones…
-
National Healthy Lifestyle Promotion Month | Focusing on Breast Health: Authoritative Experts Discuss Breast Cancer Prevention and Treatment — Part I
Professor Jianyun NieYunnan Cancer Hospital With the continuous progress of medicine, curing breast cancer is gradually becoming possible. We once again call on breast cancer patients to face the disease…
Connecting Medical Expertise through Media